Germany
The combined firm, which will operate under the Venner Shipley name and have 46 partners, will go live in December
Counsel in Germany, Brazil, and Colombia explain what a US ruling on anti-suit injunctions in a FRAND case means for their advice to clients
In the second article in a regular series covering Unified Patent Court developments, Managing IP summarises a recent Court of Appeal ruling and looks ahead to upcoming hearings at the local divisions
Metaverse-related inquiries have died down but there are some takeaways that practitioners have gained from the hype
Sponsored
Sponsored
-
Sponsored by MaiwaldIn the present case (X ZR 14/20), the German Federal Court of Justice again dealt with the question to what extent a third party who is not party to the nullity proceedings should be granted access to the files of the nullity proceedings. -
Sponsored by Bird & BirdRichard Vary, Clemens Heusch and Matthias Schneider reveal their views on component-level versus end-point licensing and Unwired Planet
-
Sponsored by MaiwaldIn Germany, inventions which are created by employees during the term of their employment, so-called service inventions, are subject to the Act on Employees' Inventions (ArbnErfG). According to the act, all rights in the invention are assigned to the employer if the employer does not release the invention to the employee.
-
Sponsored by MaiwaldIn the present case, the German Federal Court of Justice again had to deal with the question of how a representation of information within the meaning of Article 52(2)(d) EPC is to be distinguished from a technical feature.
-
Sponsored by MaiwaldThe European Commission, the European Medicines Agency (EMA) and the relevant national authorities recently agreed on a number of measures to mitigate the impact of COVID-19 disruptions on the conduct of inspections at manufacturing sites or other sites relevant to medicinal products in the European Union. These are included in the Notice to stakeholders: Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic, https://ec.europa.eu/health/sites/health/files/human-use/docs/guidance_regulatory_covid19_en.pdf.
-
Sponsored by MaiwaldIn the future, it will be more difficult to obtain an injunction for patent infringement through preliminary injunction proceedings.
